UNAIDS welcomed the agreement between ViiV and the Medicines Patent Pool to enable access to generic formulation of long acting Cabotegravir for PrEP to...
Existing guidelines require PrEP users to get tested for HIV, sexually transmitted infections (STI) and renal function periodically. And this could have an effect...